This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2013
  • /
  • 09
  • /
  • No evidence of benefits to cognition with omega-3 ...
Drug news

No evidence of benefits to cognition with omega-3 fatty acids

Read time: 1 mins
Last updated:28th Sep 2013
Published:28th Sep 2013
Source: Pharmawand

A new study of the effects of omega-3 fatty acids finds no evidence of improved cognition in those consuming the oil. A total of 2,157 women with normal cognition enrolled in a clinical trial of postmenopausal hormone therapy were followed with annual cognitive testing for a median of 5.9 years.

After adjustment for demographic and other characteristics, no significant cross-sectional cognitive differences were found between women in the high and low DHA + EPA tertiles at the time of the first annual cognitive tests. In addition, no significant differences were found between the high and low DHA + EPA tertiles in the rate of cognitive change over time. The results have been published in Neurology: "Omega-3 fatty acids and domain-specific cognitive aging" Eric M. Ammann et al. Neurology September 25, 2013, doi: 10.1212/WNL.0b013e3182a9584c

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.